G Yamshchikov,
L Thompson,
WG Ross,
H Galavotti,
W Aquila,
D Deacon,
J Caldwell,
JW Patterson,
DF Hunt,
CL Slingluff.
(2001)
" Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.
"
Clin Cancer Res
7.
909s-916s
PMID:
11300491
|
Abstract and Keywords
GV Yamshchikov,
DL Barnd,
S Eastham,
H Galavotti,
JW Patterson,
DH Deacon,
D Teates,
P Neese,
WW Grosh,
G Petroni,
VH Engelhard,
CL Slingluff.
(2001)
" Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.
"
Int J Cancer
92.
703-11
PMID:
11340576
|
Abstract and Keywords
CL Slingluff,
G Yamshchikov,
P Neese,
H Galavotti,
S Eastham,
VH Engelhard,
D Kittlesen,
D Deacon,
S Hibbitts,
WW Grosh,
G Petroni,
R Cohen,
C Wiernasz,
JW Patterson,
BP Conway,
WG Ross.
(2001)
" Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.
"
Clin Cancer Res
7.
3012-24
PMID:
11595689
|
Abstract and Keywords
TN Bullock,
DW Mullins,
TA Colella,
VH Engelhard.
(2001)
" Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice.
"
J Immunol
167.
5824-31
PMID:
11698456
|
Abstract and Keywords
D Oertli,
WR Marti,
P Zajac,
C Noppen,
T Kocher,
E Padovan,
M Adamina,
R Schumacher,
F Harder,
M Heberer,
GC Spagnoli.
(2002)
" Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo.
"
Hum Gene Ther
13.
569-75
PMID:
11874634
DOI:
10.1089/10430340252809856
|
Abstract and Keywords
DA Newton,
PM Acierno,
FJ Brescia,
EA Brown,
S Gattoni-Celli.
(2002)
" Semi-allogeneic vaccines for patients with cancer and AIDS.
"
J Immunother
25.
334-41
PMID:
12142556
|
Abstract and Keywords
TN Bullock,
DW Mullins,
VH Engelhard.
(2003)
" Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.
"
J Immunol
170.
1822-9
PMID:
12574347
|
Abstract and Keywords
LH Butterfield,
A Ribas,
VB Dissette,
SN Amarnani,
HT Vu,
D Oseguera,
HJ Wang,
RM Elashoff,
WH McBride,
B Mukherji,
AJ Cochran,
JA Glaspy,
JS Economou.
(2003)
" Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.
"
Clin Cancer Res
9.
998-1008
PMID:
12631598
|
Abstract and Keywords
AL Glazyrin,
J Kan-Mitchell,
ML Mitchell.
(2003)
" Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells.
"
Cancer Immunol Immunother
52.
171-8
PMID:
12649746
DOI:
10.1007/s00262-002-0339-6
|
Abstract and Keywords
SO Dionne,
MH Smith,
FM Marincola,
DF Lake.
(2003)
" Functional characterization of CTL against gp100 altered peptide ligands.
"
Cancer Immunol Immunother
52.
199-206
PMID:
12669244
DOI:
10.1007/s00262-002-0358-3
|
Abstract and Keywords